NNS 2026

All Sessions by Todd Kilbaugh

5:15 pm - 7:00 pm

POB.130 - Clinical Trial of Inhaled Nitric Oxide for Treatment of Microvascular Dysfunction in Acute Traumatic Brain Injury: Preliminary Report

5:15 pm - 7:00 pm

POB.158 - Fc-Engineered Monoclonal Antibodies Targeting neoGFAP™ as a Disease-Modifying Immunotherapy for Traumatic Brain Injury